Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-05-27

Clinical Trial Update: Medication in Early Diabetes (MED) Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial called Medication in Early Diabetes (MED) investigating Type 2 diabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Menzies School of Health Research | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: WITHDRAWN